Interní Med. 2006; 8(4): 172-178

Prevention and treatment of thromboembolism disease in 2006

prof. MUDr. Jaroslav Malý CSc¹, prof. MUDr. Jiří Widimský DrSc., FESC²

¹ I. interní klinika Fakultní nemocnice v Hradci Králové

² II. interní klinika LF UK a Fakultní nemocnice, Hradec Králové

In surgery it is possible draw up fundamentals prophylaxis of venous thromboembolism this way: a) Mini heparin and low molecular heparin (LMWH) decline occurrence symptom – free and endeictic venous thrombosis and fatal pulmonary embolism when about 60% and decline all causes death. b) Mini heparin and LMWH have similar sensitiveness and safeness. c) In oncology has serve LMWH in higher dues. In longitude treatment venous thromboembolism with exert these fundamentals: a) near ill with heckled distal venous thrombosis is short – term secondary prophylaxis sufficient, b) secondary prevention longer than 6 month is fit near: active oncologic dissease, bilateral recurrence, acquired or hereditary thrombophilia, unprovocated venous thrombo embolism and without recurrence. Thrombolytic treatment pulmonary embolism isn‘t in a satisfactory manner resolution and except catch it indication circulatory failure there has been gray ointment zone mediumly weighty pulmonary embolism, where inquired for sensitive detector at indication of thrombolyse.

Keywords: Key words: pulmonary embolism, prophylaxis of thromboembolism, thrombolytic therapy treatment, anticoagulant therapy.

Published: June 1, 2006  Show citation